MELD-Na scores higher at 30-day readmission for decompensated cirrhosis during pandemic

CHICAGO — Patients readmitted to the hospital within 30 days for decompensated cirrhosis during the COVID-19 pandemic had fewer comorbidities but increased MELD-Na scores, according to data at Digestive Disease Week.“Patients with decompensated cirrhosis have a high rate of hospital readmission and mortality,” Michelle Y. Shi, MD, a board-certified internist at the Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health, said during a poster presentation. “Many studies available in the literature are focusing on readmissions reported priorRead More